Table of Contents Author Guidelines Submit a Manuscript
Neurology Research International
Volume 2017, Article ID 3549291, 6 pages
Clinical Study

Efficacy of Keyhole Approach to Carpal Tunnel Syndrome under Ambulatory Strategy

Translational Institute of Neuroscience, Department of Neuroscience, CUCS, University of Guadalajara, Guadalajara, JAL, Mexico

Correspondence should be addressed to Rodrigo Ramos-Zúñiga; moc.liamg@31zrogirdor

Received 30 August 2016; Revised 3 January 2017; Accepted 22 January 2017; Published 6 April 2017

Academic Editor: Jeff Bronstein

Copyright © 2017 Rodrigo Ramos-Zúñiga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The carpal tunnel syndrome is one of the most common entrapment neuropathies found in humans. Currently, the gold standard is surgical treatment using different modalities. The minimally invasive strategy with high resolution capacity and less morbidity is still a challenge. Methods. Prospective nonrandomised clinical trial in which a minimally invasive microsurgical approach was used following the keyhole principle in 55 consecutive patients and 65 hands under local anesthesia and ambulatory strategy. They were evaluated with stringent inclusion criteria with the Levine severity and functional status scale and with a 2-year follow-up. Results. 90% showed immediate improvement dropping to grades 1-2 in all items of the scale referring to pain and numbness. 97% reported improvement, as of the first month, and 3% reported persistence of symptoms, although at a lesser degree and with no functional limitation. No incidents were identified during the procedure and 98% of patients were discharged within an hour after the surgical procedure. Conclusions. The microsurgical approach described following the keyhole principle is a treatment option that, under local anesthesia and ambulatory management, may represent an alternative strategy of an effective treatment reducing the morbidity. This trial is registered with Clinical Trials Protocol Identifier NCT03062722.